Over
Dr Alzouebi is a Consultant Clinical Oncologist at Weston Park Hospital, specialising in the treatment of cancers of the urinary tract, particularly prostate, kidney, and bladder cancer. She is an expert in using the most advanced and up-to-date treatment modalities, including systemic anti-cancer chemotherapy, immunotherapy, and radiotherapy. Dr Alzouebi is actively involved in clinical trials and research, and is the local principal investigator on several national clinical trials.
She completed her general medical training in the Yorkshire Deanery, achieving MRCP and DTMH qualifications, and completed the Clinical Oncology Training Programme at Weston Park Hospital in Sheffield. She obtained a Distinction in a Master’s Degree in Oncology from the University of Nottingham and her dissertation research was published in a peer-reviewed journal. Dr Alzouebi holds a substantive NHS post as a Consultant Clinical Oncologist at Sheffield Teaching Hospital NHS Foundation Trust.
Her treatments include Systemic Drug Therapy/Chemotherapy (Novel Targeted Anticancer Drug Treatment, Systemic Chemotherapy, Immunotherapy, Monoclonal Antibodies, Endocrine Therapy, Radium-223, and Tyrosine Kinase therapy) and Radiotherapy (Intensity Modulated Radiotherapy, Image Guided Radiotherapy, Adaptive Radiotherapy, Stereotactic Ablative Radiotherapy, and SABR). Her areas of interest include Advanced Radiotherapy Techniques for Prostate and Bladder Cancer, Prostate SABR, and Chemotherapy in Prostate, Kidney, and Bladder Cancer. Dr Alzouebi also works in partnership with Genesiscare to offer SpaceOAR for prostate radiotherapy.
She completed her general medical training in the Yorkshire Deanery, achieving MRCP and DTMH qualifications, and completed the Clinical Oncology Training Programme at Weston Park Hospital in Sheffield. She obtained a Distinction in a Master’s Degree in Oncology from the University of Nottingham and her dissertation research was published in a peer-reviewed journal. Dr Alzouebi holds a substantive NHS post as a Consultant Clinical Oncologist at Sheffield Teaching Hospital NHS Foundation Trust.
Her treatments include Systemic Drug Therapy/Chemotherapy (Novel Targeted Anticancer Drug Treatment, Systemic Chemotherapy, Immunotherapy, Monoclonal Antibodies, Endocrine Therapy, Radium-223, and Tyrosine Kinase therapy) and Radiotherapy (Intensity Modulated Radiotherapy, Image Guided Radiotherapy, Adaptive Radiotherapy, Stereotactic Ablative Radiotherapy, and SABR). Her areas of interest include Advanced Radiotherapy Techniques for Prostate and Bladder Cancer, Prostate SABR, and Chemotherapy in Prostate, Kidney, and Bladder Cancer. Dr Alzouebi also works in partnership with Genesiscare to offer SpaceOAR for prostate radiotherapy.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Mymoona Alzouebi
Opleiding & training
-
2005–2011 MD · Medicine and Surgery
-
2011–2015 Residency · Oncologie
Carrière & aanstellingen
-
2015-09–2016-08 Junior consultant
Vergunningen & verzekering
Medische licenties
GB — Organización Médica Colegial de España (OMC)
Boardcertificeringen
European Board of Oncologie
Beroepsaansprakelijkheidsverzekering:
AXA Healthcare Liability · 1,000,000 EUR dekking · No claims on file
Uitgevoerde procedures
| Procedure | Code | Levenslang aantal |
|---|---|---|
| GP consultation | 99213 | 1,819 |
| Annual physical exam | 99395 | 1,237 |
| Vaccination administration | 90471 | 1,053 |
| Minor procedure (skin) | 17110 | 586 |
Diensten & prijzen
| Dienst | Duur | Modaliteit | Prijs |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 90 min | in_clinic | 360.00 EUR |
| Minor procedure (skin) | 60 min | in_clinic | 270.00 EUR |
Praktijk, team & in praktijk
Video's
Onderzoek & publicaties
h-index: 15 · i10: 15
-
Long-term follow-up of Oncologie across GB
DOI: 10.9711/euroclin.2026.0 · PMID: 36234510 · geciteerd door 187
-
Validation of clinical scoring in Oncologie
DOI: 10.9456/euroclin.2025.1 · PMID: 31706029 · geciteerd door 81
-
Long-term follow-up of Oncologie across GB
DOI: 10.9648/euroclin.2024.2 · PMID: 36028681 · geciteerd door 39
-
Validation of clinical scoring in Oncologie
DOI: 10.3301/euroclin.2023.3 · PMID: 37363220 · geciteerd door 37
Uitgenodigde lezingen
- Practical updates in Oncologie European Annual Congress (Oncologie) · Vienna · 2024 · invited
- Single-centre experience in Oncologie National Society Meeting · Sheffield · 2023 · oral abstract
Onderscheidingen & lidmaatschappen
Onderscheidingen
- 🏆 Top-rated Oncologie — Sheffield · EuroClinics Patient Choice · 2025 · regional
Lidmaatschappen
- WONCA Europe — Family Doctors — Member · Sinds 2016
- national college of family doctors — Member · Sinds 2016
- European Union of Medical Specialists (UEMS) — Member · Sinds 2016
Artikelen van deze arts
- Patient education Patient guide to Oncologie
- Awareness When should you see a oncologie?
Voor internationale patiënten
- Coördinator
- Patient liaison · dr.mymoona.alzouebi@euroclinics.example
Locatie
1 tagPatiëntbeoordelingen
Deel uw ervaring — help andere patiënten de juiste arts te vinden. Schrijf een recensie →
Recente recensies
-
★★★★★ ✓ Geverifieerd Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Geverifieerd Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Geverifieerd Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
Vergelijkbare specialisten
Alles bladeren →
Mr Abdulla Alhasso
Oncologie · Glasgow
Dr Alexander McDonald
Oncologie · Glasgow
Dr Amna Sheri
Oncologie · London
Dr Angus Robinson
Oncologie · Horley
Dr Anne Armstrong
Oncologie · Manchester
Dr Ashraf Azzabi
Oncologie · Washington
Dr Clare Green
Oncologie · Winchester
Dr Desmond Yip
Oncologie · Garran